Zarzia is supporting a Swiss company on a complex multichannel project that will be rolled out globally to all of its affiliates

Zarzia is supporting a global Ox pharma company assessing strategic & tactical fit of early-assets on the oncology area.  

We are supporting an old customer with the outlicensing of their product portfolio in Asian geographies, after having helped with the introduction of their core asset in Europe.  

Zarzia is supporting a European company expanding their mature portfolio across selected geographies

Zarzia will be helping an international client on finding a suitable in-licensing partner for an innovative patented speciality high-value product in Russia, CIS & C&EE selected markets.